
eISSN : 2964-7584
ISSN : 3032-467X
DOI Prefix : 10.58815
Jurnal Farmasi Klinik - Best Practice (JFKlin) receives manuscript from the results of research (research article), systematic reviews and meta analysis that are closely related to the health sector, particularly the pharmaceutical field. Selected manuscripts for publication in JFKlin will be sent to two reviewers expert in their field, who are not affiliated with the same institution as the author(s), and are chosen based on the consideration of the editorial team. The review process is conducted in a closed manner where the author(s) and reviewers do not know the identity and affiliation of each. Each manuscript delegated to editorial members is examined for the final decision of the review process. The author(s) are required to respond to the review given and send revised manuscripts within the allotted time after the comments and suggestions from the reviewers have been sent. Manuscripts accepted for publication are edited copies checked for the grammar, punctuation, print style, and format. The entire process of submitting the manuscripts to the final decision for publishing is done online.
Jurnal Farmasi Klinik - Best Practice (JFKlin) has been covered by these following indexing services.
Current Issue
Vol. 5 No. 1 (2026): Jurnal Farmasi Klinis Best Practice Volume 5 No. 1 Juni 2026
Jurnal Farmasi Klinis Best Practice Volume 5 No. 1 Juni 2026
DOI: https://doi.org/10.58815/jfklin.v5i1
Published: 2026-06-29
Article
EVALUATION OF THE EFFECT OF TRASTUZUMAB AND NON-TRASTUZUMAB THERAPY ON OVERALL SURVIVAL AND PROGNOSIS OF HER2-POSITIVE BREAST CANCER at FATMAWATI HOSPITAL JAKARTA 2019-2024.
Page : 1-10
Pdf Download: 49



